Metformin Associated with Reduced Mortality in CKD, CHF, and CLD

annals.org
metformin-associated-with-reduced-mortality-in-ckd-chf-and-cld

Metformin is currently the suggested initial treatment for type 2 diabetes mellitus in the United States. In the past, the U.S. Food and Drug Administration (FDA) did not recommend metformin for patients with chronic kidney disease (CKD), congestive heart failure (CHF), and/or chronic liver disease (CLD) with hepatic impairment.

Read More